13 completed, 3 recruiting, 3 terminated, 3 unknown. .
Follow None (Observational study): new trials by email Literature Review of None (Observational study) trials Research Report on None (Observational study)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Registry of Exposure to Gepotidacin (PREG) None (Observational study) - Sexually Transmitted Diseases | Not yet recruiting | GlaxoSmithKline | 614 | 2026-09-30 | 2026-09-30 | |
| Evaluation of Anterior Neck Ultrasound in Predicting Difficult Airway in Obese Patients None (Observational study) - Ultrasonography, Airway Management | Not yet recruiting | Gaziantep City Hospital | 52 | 2026-09-20 | 2026-09-10 | |
| QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol None (observational study) - Asthma | Completed | AstraZeneca | 8681 | 2026-08-03 | 2026-10-26 | |
| Determinant Factors in Excessive Gestational Weight Gain: Physical Activity, Nutritional Status, and Anxiety None (Observational Study) - Pregnancy, Excessive Gestational Weight Gain | Recruiting | Bezmialem Vakif University | 150 | 2026-01-02 | 2026-07-21 | |
| GRANITE: Airsupra Effectiveness in the Real World None (Observational study) - Asthma | Completed | AstraZeneca | 4060 | 2025-07-09 | 2026-06-12 | |
| Maternal Oral Microbiota and Immune Signatures Associated With Spontaneous Labor Onset None (Observational Study) - Labor Onset | Completed | Third Affiliated Hospital, Sun Yat-Sen University | 55 | 2025-01-22 | 2026-09-24 | |
| The Effects of HER2 Receptor Signaling on Human Brown Fat Activity None (Observational study) - Breast Cancer | Recruiting | Copenhagen University Hospital, Rigshospitalet | 30 | 2024-11-14 | 2024-11-19 | |
| Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN None (Observational study) - Lupus Nephritis | Recruiting | GlaxoSmithKline | 300 | 2024-10-04 | 2026-07-02 | |
| Assessment of Taurine Concentration in Older Women With/Without Obesity And With/Without Type 2 Diabetes Mellitus None (Observational study) - Obesity and Type 2 Diabetes | Unknown | University of Sao Paulo | 40 | 2024-02-28 | 2024-09-23 | |
| Evaluation Of DNA Methylation Pattern In Healthy, Sarcopenic, Obese And Sarcopenic Obese Older Women: A Cross-Sectional Study None (Observational Study) - Sarcopenic Obesity, Sarcopenia | Unknown | University of Sao Paulo | 32 | 2024-02-21 | 2024-10-02 | |
| Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD None (Observational Study) - Non-Small Cell Lung Cancer | Terminated | AstraZeneca | 83 | 2024-01-05 | 2026-05-04 | |
| A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment None (Observational study) - Major Bleeding | Completed | AstraZeneca | 2202 | 2023-12-04 | 2025-11-03 | |
| Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs. None (Observational study) - Systemic Lupus Erythematosus | Completed | AstraZeneca | 46 | 2023-10-27 | 2025-05-13 | |
| A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer None (Observational Study) - Advanced Ovarian Cancer | Completed | AstraZeneca | 24 | 2023-07-10 | 2024-09-20 | |
| An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer None (Observational Study) - Breast Cancer | Terminated | AstraZeneca | 78 | 2023-07-07 | 2024-11-07 | |
| Economic Burden of Knee Osteoarthritis in Talavera de la Reina Health Area. None (Observational study) - Knee Osteoarthritis | Unknown | University of Castilla-La Mancha | 400 | 2023-04-01 | 2023-12-06 | |
| A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice. None (Observational study) - Systemic Lupus Erythematosus | Active not recruiting | AstraZeneca | 551 | 2023-02-27 | 2026-09-24 | |
| A Study for Observing Severe Asthma in Patients Treated With Tezepelumab None (Observational Study) - Asthma | Completed | AstraZeneca | 513 | 2022-12-13 | 2026-03-16 | |
| A Study of the Natural Course of SURF1 Deficiency None (Observational study) - Leigh Syndrome | Withdrawn | Taysha Gene Therapies, Inc. | 2022-05-04 | 2022-05-20 | ||
| Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 None (Observational study) - Coronavirus Disease 2019 (COVID-19) | Terminated | AstraZeneca | 27 | 2021-05-31 | 2022-06-30 |
Showing 20 of 26. Sign in to see all of them.
Breast Neoplasms (4) · Asthma (3) · Obesity (3) · Anxiety Disorders (2) · Lupus Erythematosus, Systemic (2) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Depression (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Financial Stress (1) · Leigh Disease (1) · Leukemia, Myeloid, Acute (1) · Lung Diseases, Interstitial (1) · Lupus Nephritis (1)
AstraZeneca (12) · GlaxoSmithKline (2) · University of Sao Paulo (2) · Bezmialem Vakif University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Gaziantep City Hospital (1) · German Cancer Research Center (1) · Taysha Gene Therapies, Inc. (1) · Third Affiliated Hospital, Sun Yat-Sen University (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Hospital, Grenoble (1) · University of Castilla-La Mancha (1) · University of Manchester (1)
United States (10) · Germany (6) · Italy (6) · France (5) · United Kingdom (5) · Brazil (4) · Canada (4) · Israel (4) · Austria (3) · Japan (3) · Spain (3) · Australia (2) · Belgium (2) · Denmark (2) · Portugal (2)
Ashley L Bryant, PhD, RN (1) · Elena Moro (1) · Gamze Nur Teke, medical doctor (1) · Ya-Ning Chan, MSN, RN (1)
PMID 23263599, PMID 28725706, PMID 28805564, PMID 29436490, PMID 30363450, PMID 32860177, PMID 32893501, PMID 36314131, PMID 36844111, PMID 37546081, PMID 37562195, PMID 38812631, PMID 38905928, PMID 39578022, PMID 41903429, PMID 42562237
2023 (1)